Top compounds associated with response to SEC62


Feature Type Standardized
Nominal ANOVA
mRNA bid1870 gCSI pan-cancer AAC -0.055 0.3
mRNA Rapamycin gCSI pan-cancer AAC 0.035 0.5
mRNA Crizotinib gCSI pan-cancer AAC 0.02 0.7
mRNA Vorinostat gCSI pan-cancer AAC -0.0071 0.9
mRNA MS-275 gCSI pan-cancer AAC 0.0028 1
mRNA Erlotinib gCSI pan-cancer AAC -0.0018 1
Download CSV